Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis

被引:89
作者
Mok, Chi Chiu [1 ]
Birmingham, Daniel J. [2 ]
Leung, Hoi Wah [1 ]
Hebert, Lee A. [2 ]
Song, Huijuan [2 ]
Rovin, Brad H. [2 ]
机构
[1] Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Ohio State Univ, Med Ctr, Dept Med, Columbus, OH 43210 USA
关键词
vitamin D; atherosclerosis; cholecalciferol; disease activity; traditional risk factors; NUTRITION EXAMINATION SURVEY; 25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; CARDIOVASCULAR RISK; 1,25-DIHYDROXYVITAMIN D-3; AUTOIMMUNE-DISEASES; NATIONAL-HEALTH; D-RECEPTOR; SLE; PREVALENCE;
D O I
10.1093/rheumatology/ker212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To study the relationship of 25(OH)D-3 level with disease activity, vascular risk factors and atherosclerosis in SLE. Methods. Consecutive patients who fulfilled four or more ACR criteria for SLE were recruited for assay of 25(OH)D-3 level. Disease activity was assessed by the SLEDAI and physicians' global assessment (PGA). Patients with vascular risk factors were screened for atherosclerosis at the coronary or carotid arteries. Correlation between 25(OH)D-3 levels and SLEDAI scores was studied by linear regression. The link between vascular risk factors, atherosclerosis and vitamin D deficiency was also examined. Results. A total of 290 SLE patients were studied [94% women; mean (s.d.) age 38.9 (13.1) years; disease duration 7.7 (6.7) years; 78% patients had clinical or serological lupus activity]. Two hundred and seventy-seven (96%) patients had vitamin D insufficiency [25(OH)D-3 < 30 ng/ml] and 77 (27%) patients had vitamin D deficiency (< 15 ng/ml). Levels of 25(OH)D-3 correlated inversely with PGA (beta -0.20; P = 0.003), total SLEDAI scores (beta -0.19; P = 0.003) and subscores due to active renal, musculoskeletal and haematological disease. Subjects with vitamin D deficiency had significantly higher total/high-density lipoprotein (HDL) cholesterol ratio [3.96 (2.94) vs 3.07 (0.80); P = 0.02] and prevalence of aPLs (57 vs 39%; P = 0.007). Of 132 patients, 58 (44%) with vascular risk factors screened were positive for subclinical atherosclerosis. No association could be demonstrated between 25(OH)D-3 level and atherosclerosis, which was mainly associated with increasing age, menopause, obesity and hyper-triglyceridaemia. Conclusions. In this large cross-sectional study of SLE patients, 25(OH)D-3 level correlates inversely with disease activity. Vitamin D deficiency is associated with dyslipidaemia. In patients with vascular risk factors, subclinical atherosclerosis is not associated with hypovitaminosis D.
引用
收藏
页码:644 / 652
页数:9
相关论文
共 36 条
[21]   Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus [J].
Mok, CC .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (02) :85-95
[22]   Novel biomarkers in autoimmune diseases - Prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases [J].
Orbach, Hedi ;
Zandman-Goddard, Gisele ;
Amital, Howard ;
Barak, Vivian ;
Szekanecz, Zoltan ;
Szucs, Gabriella ;
Danko, Katalin ;
Nagy, Endre ;
Csepany, Tunde ;
Carvalho, Jozelio F. ;
Doria, Andrea ;
Shoenfeld, Yehuda .
AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS, 2007, 1109 :385-400
[23]  
PETRI M, 1992, J RHEUMATOL, V19, P53
[24]   The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3 [J].
Pike, J. Wesley ;
Meyer, Mark B. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (02) :255-+
[25]   Mechanisms of disease: Systemic lupus erythematosus [J].
Rahman, Anisur ;
Isenberg, David A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (09) :929-939
[26]   Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis [J].
Reis, Jared P. ;
von Muehlen, Denise ;
Michos, Erin D. ;
Miller, Edgar R., III ;
Appel, Lawrence J. ;
Araneta, Maria R. ;
Barrett-Connor, Elizabeth .
ATHEROSCLEROSIS, 2009, 207 (02) :585-590
[27]   Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences [J].
Ruiz-Irastorza, G. ;
Egurbide, M. V. ;
Olivares, N. ;
Martinez-Berriotxoa, A. ;
Aguirre, C. .
RHEUMATOLOGY, 2008, 47 (06) :920-923
[28]   DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 [J].
Sigmundsdottir, Hekla ;
Pan, Junliang ;
Debes, Gudrun F. ;
Alt, Carsten ;
Habtezion, Aida ;
Soler, Dulce ;
Butcher, Eugene C. .
NATURE IMMUNOLOGY, 2007, 8 (03) :285-293
[29]   A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage [J].
Steinman, Lawrence .
NATURE MEDICINE, 2007, 13 (02) :139-145
[30]   The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary [J].
Szodoray, P. ;
Tarr, T. ;
Bazso, A. ;
Poor, G. ;
Szegedi, G. ;
Kiss, E. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 (02) :122-126